| Literature DB >> 21977055 |
Seil Jung1, Eun-Nam Lee, Sook-Ryon Lee, Mi-Sook Kim, Myeong Soo Lee.
Abstract
Tai chi exercise has been recommended as suitable for the improvement of health in the elderly. The purpose of this study was to investigate the effects of tai chi on lower urinary tract symptoms (LUTSs), quality of life (QoL), and sex hormone levels in patients with benign prostate hypertrophy (BPH). The elderly patients with BPH were randomized to receive tai chi or usual care. Fifty-six participants were randomized into either the tai chi group (n = 28) or the control group (n = 28). After 12 weeks of treatment, the tai chi group showed significant improvement in LUTS and QoL. There was a significant effect of tai chi on testosterone but no significant effect on insulin or glucose. No serious adverse events were observed during the study period. In conclusion, our results suggest that 12 weeks of tai chi may improve LUTS and QoL in elderly patients with BPH.Entities:
Year: 2011 PMID: 21977055 PMCID: PMC3185236 DOI: 10.1155/2012/624692
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1A diagram of the study design, showing the flow of participants.
The demographic characteristics of the subjects.
| Tai Chi ( | Control group ( |
|
| |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | |||
|
| ||||
| Age (yr) | 71.79 ± 3.38 | 69.57 ± 5.81 | 1.23 | .23 |
|
| ||||
| Number (%) | Number (%) | |||
|
| ||||
| Married | ||||
| Yes | 14 (100) | 12 (92) | 1.19 | .48 |
| No | 0 (0) | 1 (8) | ||
| Educational level | ||||
| Junior high | 2 (15) | 5 (36) | 4.53 | .10 |
| High | 3 (23) | 6 (43) | ||
| College | 8 (62) | 3 (21) | ||
| Employed | ||||
| Yes | 3 (21) | 1 (7) | 1.17 | .60 |
| No | 11 (79) | 13 (93) | ||
| Monthly income (in ten thousand Won) | ||||
| <100 | 6 (44) | 7 (50) | .89 | .93 |
| 100–150 | 3 (21) | 4 (29) | ||
| 151–200 | 2 (14) | 1 (7) | ||
| 201–250 | 3 (21) | 2 (14) | ||
| Perceived health status | ||||
| Healthy | 4 (29) | 5 (36) | .60 | 1.00 |
| Average | 8 (57) | 6 (43) | ||
| Bad | 2 (14) | 3 (21) | ||
| Surgical history for the prostate | ||||
| Yes | 2 (14) | 1 (7) | .37 | .54 |
| No | 12 (86) | 13 (93) | ||
| Medication for the prostate | ||||
| Yes | 6 (43) | 8 (57) | .57 | .71 |
| No | 8 (57) | 6 (43) | ||
| Exercise | ||||
| Yes | 9 (64) | 13 (93) | 3.39 | .17 |
| No | 5 (36) | 1 (7) | ||
SD: standard deviation.
Homogeneity tests of the outcomes between the groups.
| Outcome | Tai chi ( | Control ( |
|
|
|---|---|---|---|---|
| IPSS | 13.07 ± 7.96 | 16.36 ± 8.86 | −1.03 | 0.31 |
| QoL of BPH | 43.64 ± 20.44 | 45.43 ± 19.78 | −0.24 | 0.87 |
| urination-related discomfort | 12.43 ± 6.45 | 12.43 ± 6.66 | 0.001 | 1.00 |
| Worry & concern | 6.57 ± 3.86 | 6.14 ± 3.51 | 0.31 | 0.76 |
| Interference with daily activities | 11.57 ± 4.11 | 10.50 ± 4.27 | 0.68 | 0.51 |
| Testosterone (ng/mL) | 4.01 ± 1.05 | 3.65 ± 1.62 | 0.70 | 0.49 |
| Insulin ( | 11.30 ± 10.41 | 17.40 ± 29.05 | −0.74 | 0.47 |
| Blood glucose (mg/dL) | 123.43 ± 26.12 | 128.21 ± 28.89 | −0.46 | 0.65 |
| QUICKI | 0.35 ± 0.06 | 0.44 ± 0.41 | −0.79 | 0.44 |
Values are expressed as mean ± standard deviation; IPSS: international prostate symptoms score; QoL of BPH: quality of life of benign prostate hyperplasia
QUICKI: quantitative insulin sensitivity check index.
Effects of tai chi on IPSS, QoL, and biochemical outcomes.
| Outcome | Tai chi ( | Control ( |
|
| ||||
|---|---|---|---|---|---|---|---|---|
| Before | After | After-Before | Before | After | After-Before | |||
| IPSS | 13.07 ± 7.96 | 8.93 ± 3.38 | −4.14 ± 7.16 | 16.36 ± 8.86 | 17.07 ± 9.04 | .71 ± 2.87 | −2.36 | 0.03 |
| QoL of BPH (Total) | 43.64 ± 20.44 | 33.07 ± 12.38 | −10.57 ± 14.76 | 45.43 ± 19.79 | 48.50 ± 19.51 | 3.07 ± 7.84 | −3.06 | 0.005 |
| QoL of BPH (subscale) | ||||||||
| urination-related discomfort | 12.43 ± 6.45 | 10.00 ± 4.90 | −2.43 ± 5.69 | 12.43 ± 6.66 | 13.29 ± 6.47 | 0.86 ± 2.21 | −2.01 | 0.06 |
| Worry & concern | 6.57 ± 3.86 | 4.57 ± 3.69 | −2.00 ± 2.11 | 6.14 ± 3.51 | 6.43 ± 3.39 | .29 ± 2.79 | −2.45 | 0.02 |
| Interference with daily activities | 11.57 ± 4.11 | 9.57 ± 4.11 | −2.00 ± 3.23 | 10.50 ± 4.27 | 11.71 ± 5.59 | 1.21 ± 5.31 | −1.94 | 0.06 |
| Testosterone (ng/mL) | 4.01 ± 1.05 | 6.06 ± 1.91 | 2.05 ± 1.65 | 3.65 ± 1.62 | 4.17 ± 1.56 | 0.52 ± 1.08 | 2.92 | 0.007 |
| Insulin ( | 11.30 ± 10.41 | 3.97 ± 3.39 | −7.33 ± 8.66 | 17.40 ± 29.05 | 11.16 ± 19.62 | −6.23 ± 12.28 | −0.27 | 0.79 |
| Blood glucose (mg/dL) | 123.43 ± 26.12 | 114.07 ± 21.77 | −9.36 ± 16.29 | 128.21 ± 28.89 | 119.43 ± 21.77 | −8.79 ± 17.01 | −0.09 | 0.93 |
| QUICKI | 0.35 ± 0.06 | 0.48 ± 0.31 | 0.13 ± 0.23 | 0.44 ± 0.41 | 0.38 ± 0.07 | −0.06 ± 0.41 | 1.38 | 0.18 |
The value are expressed as mean ± standard deviation; IPSS: international prostate symptoms score; QoL of BPH: quality of life of benign prostate hyperplasia; QUICKI: quantitative insulin sensitivity check index.